Trinity Biotech plc earnings per share and revenue
On --, TRIB reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.17 USD, with revenue projected to reach 18.36 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
What were Trinity Biotech plc's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Trinity Biotech plc reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Trinity Biotech plc's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Trinity Biotech plc expected to report next?
The next earning report is scheduled for 03 de abr. de 2026.
What are the forecasts for Trinity Biotech plc's next earnings report?
Based on 3
analistas, Trinity Biotech plc is expected to report EPS of -$0.17 and revenue of $18.36M for Q4 2025.